Haleon consumer health products

Haleon is a global leader in consumer healthcare, established as an independent company in 2022 following a spin-off from the pharmaceutical giant GSK (GlaxoSmithKline). Its history is rooted in the combination of GSK's consumer health division with major assets from Pfizer, creating a portfolio of household names in the oral health, pain relief, and wellness categories.

The brand's origin is tied to the United Kingdom, where it is currently headquartered and listed on the London Stock Exchange. Because Haleon manages a vast array of heritage brands like Sensodyne, Advil, and Centum, its manufacturing footprint is truly global, with state-of-the-art facilities located across Europe, North America, and Asia to serve regional markets efficiently.

As of 2024 and moving into the future, Haleon operates as a fully independent entity. It focus exclusively on the fast-growing consumer health sector, separating its consumer-facing innovations from the prescription-based pharmaceutical research that defines its former parent companies.